top of page




DNamesTM patent approvals in the EU and US
DName-iT (“the Company”) is excited to announce that in December 2024 the EU patent office gave notice of its intention to grant the...
Jan 28

DName-iT MEDICAL CLASSIFICATION PAVES THE WAY FOR COMMERCIAL DEVELOPMENT
DName-iT Holdings Limited (or ‘the Company’), backed by EMV Capital plc, is proud to announce that its DName™ platform has achieved Class...
Sep 16, 2024


Dname-iT raises £500,000 to scale-up its ground-breaking verification platform for NGS Laboratories
DName-iT Holdings Limited (“DName-iT” or the “Company”) Dname-iT raises £500,000 from EMV Capital and KU Leuven’s Gemma Frisius Fund to...
Jun 30, 2023

NetScientific invests in DName-iT
NetScientific announces investment in DName-iT bringing important improvements to diagnostic Next Generation Sequencing 7th January 2015:...
Jul 1, 2015
bottom of page